RxSight, Inc. Payments of Debt Issuance Costs
RxSight, Inc. (RXST) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-02-25
- RxSight, Inc. payments of debt issuance costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. payments of debt issuance costs for the quarter ending 2024-09-30 was -$80.00K, a 108.01% decline year-over-year.
- RxSight, Inc. payments of debt issuance costs for the quarter ending 2023-12-31 was $11.00K, a 1000.00% increase year-over-year.
- RxSight, Inc. payments of debt issuance costs for the quarter ending 2023-09-30 was $999.00K, a 49850.00% increase year-over-year.
- RxSight, Inc. payments of debt issuance costs for fiscal 2025 was $0.00.
- RxSight, Inc. payments of debt issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- RxSight, Inc. payments of debt issuance costs for fiscal 2023 was $2.23M, a 1441.38% increase from fiscal 2022.
- RxSight, Inc. payments of debt issuance costs for fiscal 2022 was $145.00K, a 9.85% increase from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$80.00K derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2024-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $80.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.01M derived: sum of 2 quarters · filed 2026-02-25 | $2.23M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $999.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.22M 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $1.23M 10-Q · filed 2024-08-05 | |||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.00K derived: sum of 2 quarters · filed 2025-02-25 | $145.00K 10-K · filed 2025-02-25 | |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $144.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $142.00K 10-Q · filed 2023-08-07 | |||
| 2021-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $10.00K derived: sum of 2 quarters · filed 2023-03-06 | $92.00K derived: sum of 3 quarters · filed 2023-03-06 | $132.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $84.00K derived: sum of 2 quarters · filed 2022-11-07 | $124.00K 10-Q · filed 2022-11-07 | $811.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $122.00K 10-Q · filed 2022-08-08 | $809.00K derived: sum of 3 quarters · filed 2022-08-08 | $809.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $40.00K 10-Q · filed 2022-05-05 | $727.00K derived: sum of 2 quarters · filed 2022-05-05 | $727.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $687.00K derived: sum of 2 quarters · filed 2022-03-08 | $687.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |